Novel Assays - 5th Drug Formulation Summit

Philadelphia, PA, February 25, 2016 (Newswire.com) - ​​By Jodi Wojcik, Top of Google News, Managing Editor
Philadelphia: Wednesday, January 27, 2016, www.topofgoogle.com

The 5th Drug Formulation, Solubility & Bioavailability Summit 2016, held in Philadelphia, at the historic venue Rittenhouse Hotel was truly a success. The three day event was produced by ExL Pharma:  a leader in developing innovative educational events that serve the healthcare community and life science research professionals. This summit  brought together thought leaders from academia, research institutes, leading pharmaceutical companies and biotech firms to facilitate partnering opportunities and advancing life science research.

More than 30 individual presenters spoke at this year’s 5th Drug Formulation, Solubility & Bioavailability summit. Over 100 executive-level delegates representing leading pharmaceutical and innovative biotechnology industry executives were also in attendance at the event. The ExL Pharma summit and venue in Philadelphia provided a fresh analysis of the major underlying drug development and performance challenges as well as new advances in novel modeling assays. www.exlevents.com

Key opinion leaders and presenters at the 5th Drug Formulation, Solubility & Bioavailability Summit included Keith Horspool, Vice President, Pharmaceutical Development – U.S., at Boehringer Ingelheim; Joachim Hoechel, Head of Clinical Pharmacokinetics at Bayer; Rene Holm, Divisional Director, Pharmaceutical Science at Lundbeck; and Filippos Kesisoglou, Senior Principal Scientist at Merck.

The 5th Drug Formulation, Solubility & Bioavailability Summit was well organized and offered two in-depth programming tracks on “Selecting Optimal Dosage Levels” and “Breakthroughs in Targeted Delivery.”  The event also featured a full-day Solubility Seminar that focused on the challenges of working with amorphous solid dispersions.  One of the most interesting presentations was “Novel Predictive Assay Design Using Artificial Membrane Systems and In Silico Modeling” by Tian Wu, Senior Scientist, Amgen.

The 5th Drug Formulation, Solubility & Bioavailability Summit offered excellent opportunities for sponsors, exhibitors, and vendors to showcase new products and foster research partnership opportunities. The exhibitors included top-notch contract research companies such as Absorption Systems, Assembly Biosciences, Catalent, Chemspeed Technologies, Cytec, Juniper Pharma Services, Patheon, Sannova Analytical, Sirius and Solid Form Solutions. Sirius displayed two powerful analytical instruments: the InForm for bio-relevant dissolution and solubility analysis of formulations and the Scissor for in vitro testing of injection site events for biopharmaceuticals. www.sirus-analytical.com

This year’s ExL Pharma fall event is the 3rd Annual Bioequivalence Summit, “Techniques and Strategies for Modeling, Delivering, and Developing the Next Generation of Generic Drugs.” It will be held on September 26-27, 2016 in Boston, Massachusetts. To learn more please visit: www.exlevents.com